Zim Laboratories Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.4x)
Concerns
- Low capital efficiency (ROCE 4.8%)
- Premium to sector peers (P/E 199x vs industry 50.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ZIMLAB · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% |
| FII | — | 0.01% | — | — | 0.21% | 0.01% |
| DII | — | — | — | — | 0.24% | 0.24% |
| Public | 66.74% | 66.74% | 66.74% | 66.73% | 66.29% | 66.49% |
Latest News
All newsZim Laboratories reports Q1FY26 financial results
*Zim Laboratories reports Q1FY26 financial results*. The company has submitted its financial results for the quarter ended June 30, 2026. Results are in line with market expectations, with **revenue at ₹127.4 crore** and **net profit at ₹8.2 crore**. No major deviations from forecasted performance were observed. 📊 *STOCKS:* $ZIMLAB | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Zim Laboratories announces general corporate updates.
*Zim Laboratories announces general corporate updates.* The company filed routine updates with the NSE, though no specific financial or operational details were disclosed. Such filings typically include minor administrative or compliance-related information. Traders should monitor for further clarifications. 📊 *STOCKS:* $ZIMLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Corporate
Zim Laboratories to hold investor meet
*Zim Laboratories to hold investor meet.* The company has scheduled an analyst and institutional investor meet to share updates. Such events typically offer insights into recent performance and strategy. No major announcements were disclosed. 📊 *STOCKS:* $ZIMLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
Zim Laboratories to host analyst and investor meet
*Zim Laboratories to host an analyst and investor meet.* The company will provide updates during the upcoming con-call. Details on financial performance or strategy may be shared. No major announcements confirmed yet. 📊 *STOCKS:* ZIMLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings